The drug regulatory process of the republic of china — taiwan's experiences in bioavailability and bioequivalence

Oliver Yoa pu Hu, Mei Ling Hsiao, li Ling Liu

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'The drug regulatory process of the republic of china — taiwan's experiences in bioavailability and bioequivalence'. Together they form a unique fingerprint.

Medicine & Life Sciences